Amneal makes and sells generic, specialty and injectable medicines and distributes pharmaceuticals to government and retail buyers. It last closed at $21.12 on Nov 20, down 1.26% on the day. The next earnings report for AMRX is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, AMRX reported EPS of -$0.06 on revenue of $862.7M, with revenue up 10.0% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months AMRX insiders bought $0 of stock on the open market and sold $7.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is AMRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AMRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AMRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AMRX · as of the Nov 20 close · updated each morning
Uptrend
The stock is 0% above its 20 day and 5% above its 50 day average. It is 23% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the 20 day average at $21.04, and the nearest resistance the swing high (Sep 21) at $21.18.
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.6%/day
Key levels
$22.1252 week high+4.7%
$21.53Pivot R1+1.9%
$21.30Pivot+0.9%
$21.18Swing high (Sep 21)+0.3%
$21.12Last close
$21.0420 day average−0.4%
$20.89Pivot S1−1.1%
$20.75Swing low (Nov 17)−1.8%
$20.1350 day average−4.7%
$18.94100 day average−10.3%
$16.28200 day average−22.9%
$11.4552 week low−45.8%
Indicators
RSI (14)
53.67
Middle of its range
Neutral
MACD
0.39
Below its signal line
Bearish
Stochastic
78.7
Middle of its range
Neutral
ADX (14)
14.3
No clear trend
Williams %R
-32.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
34.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+4.9%
Change over 10 sessions
Bullish
ATR (14)
$0.77
Typical daily range, 3.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, nearing overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 7.0%/day
Key levels
$22.1252 week high+4.7%
$21.53Pivot R1+1.9%
$21.30Pivot+0.9%
$21.18Swing high (Sep 21)+0.3%
$21.12Last close
$21.0420 day average−0.4%
$20.89Pivot S1−1.1%
$20.75Swing low (Nov 17)−1.8%
$20.1350 day average−4.7%
$18.94100 day average−10.3%
$16.28200 day average−22.9%
$11.4552 week low−45.8%
Indicators
RSI (14)
66.04
Strong, overbought above 70
Neutral
MACD
1.62
Above its signal line
Bullish
Stochastic
79.8
Middle of its range
Neutral
ADX (14)
43.6
Strong uptrend
Williams %R
-18.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
123.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+24.2%
Change over 10 sessions
Bullish
ATR (14)
$1.49
Typical daily range, 7.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AMRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AMRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AMRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AMRXHow many large options trades hit AMRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AMRX in the last 90 days.
From SEC Form 4 filings by AMRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AMRX is in one of them and how their past AMRX trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Amneal Pharmaceuticals
Amneal develops, makes, markets and distributes medicines through three business areas. Its Affordable Medicines segment offers retail generic drugs, injectable products and biosimilars, while its Specialty segment sells branded drugs mainly for central nervous system and endocrine disorders. Its AvKARE unit distributes pharmaceuticals and other products to the U.S. federal government, retail customers and institutional buyers. The company operates mainly in the United States, India and Ireland.